GENOR-B(06998) intends to appoint Ernst & Young as the new auditor.
Jiahe Biotech Group-B (06998) announced that the company plans to pass a resolution at the upcoming special shareholders' meeting to be held by the company.
GENOR-B (06998) announcement, the company intends to dismiss the company's auditor, Luo Bingxian Yongdao Accountants, at the shareholders' special meeting to be held and convened by the Company after passing the relevant resolution.
Upon the recommendation of the company's audit committee, after the proposed dismissal is effective at the extraordinary general meeting by an ordinary resolution, the Board proposes to appoint Ernst & Young as the Company's new auditor to fill the temporary vacancy caused by the proposed dismissal, with the term ending at the next annual general meeting of the Company. The proposed appointment shall be subject to approval (including) at the relevant resolution passed at the shareholders' special meeting before it can take effect.
Related Articles

Reebio's testimony: Strong technological barriers coupled with specialized and efficient pipelines, Hong Kong market welcomes scarce innovative drug targets.

New stock news | Jin Xun Group passed the hearing at the Hong Kong Stock Exchange and ranks fifth among China's cathode copper producers.

New Stock News | Jingfeng Medical has passed the hearing of the Hong Kong Stock Exchange and is committed to designing, developing, and manufacturing surgery Siasun Robot&Automation.
Reebio's testimony: Strong technological barriers coupled with specialized and efficient pipelines, Hong Kong market welcomes scarce innovative drug targets.

New stock news | Jin Xun Group passed the hearing at the Hong Kong Stock Exchange and ranks fifth among China's cathode copper producers.

New Stock News | Jingfeng Medical has passed the hearing of the Hong Kong Stock Exchange and is committed to designing, developing, and manufacturing surgery Siasun Robot&Automation.






